EpiWatch

Country:
USA
Founding year:
2017

EpiWatch is a digital health initiative developed by Johns Hopkins Medicine that provides an Apple Watch-based application for seizure monitoring and research in epilepsy. The app detects potential tonic-clonic seizure events using accelerometer and heart rate data collected from the smartwatch, generating alerts that can notify designated caregivers via a connected smartphone.

The system provides a passive seizure monitoring layer using widely available consumer hardware, making it more accessible than dedicated EEG-based seizure detection systems. In addition to event detection, the app allows users to log seizures, medications, and triggers, supporting longitudinal tracking and research data collection.

EpiWatch is primarily positioned as a research and monitoring tool rather than a regulated medical device. While it demonstrates the potential of consumer wearables in neurological monitoring, its detection capabilities are more limited than clinical-grade EEG-based systems.

Tools and Infrastructure
Diagnostics
Monitoring

Plus Insights

Modality:
Biomarkers
Form Factor:
Wearable (body)
Interface Depth:
Non-invasive
Indication:
Epilepsy
Target user:
Patients
Regulatory stage:
FDA cleared (501k)

Seed

EpiWatch occupies a distinctive niche as an Apple Watch-native seizure detection app, leveraging consumer hardware to provide passive monitoring without requiring dedicated medical wearables. Its FDA clearance and Johns Hopkins collaboration lend credibility, though tonic-clonic seizure detection sensitivity on wrist accelerometry is lower than EEG-based systems, limiting its use to a specific patient population.

Related companies

Plus Insights

Unlock more insights

Subscribe to Neurofounders+
Already have an account?  Log in
Modality:
Hidden
Form Factor:
Hidden
Interface Depth:
Hidden
Indication:
Hidden
Target user:
Hidden
Regulatory stage:
Hidden

Hidden

EpiWatch occupies a distinctive niche as an Apple Watch-native seizure detection app, leveraging consumer hardware to provide passive monitoring without requiring dedicated medical wearables. Its FDA clearance and Johns Hopkins collaboration lend credibility, though tonic-clonic seizure detection sensitivity on wrist accelerometry is lower than EEG-based systems, limiting its use to a specific patient population.

Related companies

Articles featuring

EpiWatch

No articles yet!

Press releases

No press releases published yet.